Abstract:Small animal fluorescence molecular imaging (FMI) can be a powerful tool for preclinical drug discovery and development studies. However, light absorption by tissue chromophores (e.g., hemoglobin, water, lipids, melanin) typically limits optical signal propagation through thicknesses larger than a few millimeters. Compared to other visible wavelengths, tissue absorption for red and near-infrared (near-IR) light absorption dramatically decreases and non-elastic scattering becomes the dominant light-tissue interaction mechanism. The relatively recent development of fluorescent agents that absorb and emit light in the near-IR range (600-1000 nm), has driven the development of imaging systems and light propagation models that can achieve whole body three-dimensional imaging in small animals. Despite great strides in this area, the ill-posed nature of diffuse fluorescence tomography remains a significant problem for the stability, contrast recovery and spatial resolution of image reconstruction techniques and the optimal approach to FMI in small animals has yet to be agreed on. The majority of research groups have invested in charge-coupled device (CCD)-based systems that provide abundant tissue-sampling but suboptimal sensitivity, while our group and a few others have pursued systems based on very high sensitivity detectors, that at this time allow dense tissue sampling to be achieved only at the cost of low imaging throughput. Here we demonstrate the methodology for applying single-photon detection technology in a fluorescence tomography system to localize a cancerous brain lesion in a mouse model. The fluorescence tomography (FT) system employed single photon counting using photomultiplier tubes (PMT) and information-rich time-domain light detection in a non-contact conformation. This provides a simultaneous collection of transmitted excitation and emission light, and includes automatic fluorescence excitation exposure control, laser referencing, and co-registration with a small animal computed tomography (microCT) system. A nude mouse model was used for imaging. The animal was inoculated orthotopically with a human glioma cell line (U251) in the left cerebral hemisphere and imaged 2 weeks later. The tumor was made to fluoresce by injecting a fluorescent tracer, IRDye 800CW-EGF (LI-COR Biosciences, Lincoln, NE) targeted to epidermal growth factor receptor, a cell membrane protein known to be overexpressed in the U251 tumor line and many other cancers. A second, untargeted fluorescent tracer, Alexa Fluor 647 (Life Technologies, Grand Island, NY) was also injected to account for non-receptor mediated effects on the uptake of the targeted tracers to provide a means of quantifying tracer binding and receptor availability/density. A CT-guided, time-domain algorithm was used to reconstruct the location of both fluorescent tracers (i.e., the location of the tumor) in the mouse brain and their ability to localize the tumor was verified by contrast-enhanced magnetic resonance imaging. Though demonstrated for fluorescence imaging in a glioma mouse model, the methodology presented in this video can be extended to different tumor models in various small animal models potentially up to the size of a rat.

Intravital Fluorescence Facilitates Measurement of Multiple Physiologic Functions and Gene Expression in Tumors of Live Animals

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

In vivo optical imaging of cancer cell function and tumor microenvironment

In Vivo Fluorescence Reflectance Imaging with Subcutaneous Mouse Tumor Models.

In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications

Optical Imaging: Bacteria, Viruses, and Mammalian Cells Encoding Light-Emitting Proteins Reveal the Locations of Primary Tumors and Metastases in Animals

Optical Molecular Imaging for Tumor Detection and Image-Guided Surgery.

Fluorescent imaging for cancer therapy and cancer gene therapy

In Vivo Fluorescence Imaging for Tissue Diagnostics

Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers

Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy

Compact Whole-Body Fluorescent Imaging of Nude Mice Bearing Egfp Expressing Tumor

Applications of Intravital Imaging in Cancer Immunotherapy

Role of Intravital Imaging in Nanomedicine-Assisted Anti-Cancer Therapy

Promising Approach for Optimizing In Vivo Fluorescence Imaging in a Tumor Mouse Model: Precision in Cancer Research

In vivo long-term investigation of tumor bearing mKate2 by an in-house fluorescence molecular imaging system

Visualization of GFP-expressing tumors and metastasis in vivo

Fluorescence imaging in vivo: recent advances.

Complementarity of Variable-Magnification and Spectral-Separation Fluorescence Imaging Systems for Noninvasive Detection of Metastasis and Intravital Detection of Single Cancer Cells in Mouse Models.

Clinical multi-color fluorescence imaging of malignant tumors initial experiencereview article

Laser-induced Fluorescence: Progress and Prospective for in Vivo Cancer Diagnosis